Handbook of neural engineering : a modern approach /

Provides a comprehensive overview of the field from biology to recent technological advances through an interdisciplinary lens. The book is divided into three sections: 1) Biological Considerations for Neural Engineering, 2) Neural Engineering Strategies, and 3) Emerging Technologies for Neural Engi...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Willerth, Stephanie (Editor)
Format: eBook
Language:English
Published: London ; San Diego, CA : Academic Press, [2025]
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Handbook of Neural Engineering: A Modern Approach
  • Copyright
  • Contents
  • Contributors
  • Preface
  • Acknowledgments
  • Chapter 1: Introduction to neural engineering
  • 1. Introduction
  • 2. Biomedical engineering and the evolution of neural engineering
  • 3. Biological considerations for neural engineering
  • 4. Neural engineering strategies
  • 5. Emerging technologies for neural engineering
  • 6. Conclusions
  • References
  • Section 1: Biological considerations for neural engineering
  • Chapter 2: Overview of the structure and function of the nervous system
  • 1. Introduction
  • 2. Early development of the nervous system
  • 2.1. Cell proliferation
  • 2.2. Cell migration to the cerebral neocortex and differentiation into specific cell types
  • 2.3. The formation of synapses and different regions
  • 2.4. Selective competition among connections
  • 2.5. Myelination
  • 3. Functional anatomy of the CNS
  • 3.1. Retina
  • 3.2. Spinal cord
  • 3.3. Hippocampus
  • 4. Cell types
  • 4.1. Neurons
  • 4.2. Glial cells
  • 4.3. Astrocytes
  • 4.4. Microglia
  • 4.5. Oligodendrocytes
  • 4.6. Schwann cells
  • 4.7. Radial glial cells
  • 4.8. Ependymal cells
  • 5. Neuronal communication
  • 5.1. Electrical synapses
  • 5.2. Chemical synapses
  • 5.3. Neurotransmitters and neurotransmitter receptors
  • 5.4. Glutamatergic and GABAergic signaling
  • 5.5. Synaptic integration in brain neurons
  • 6. Summary and conclusions
  • References
  • Chapter 3: Cellular biology of the central nervous system
  • 1. Introduction
  • 2. Neurons
  • 2.1. Embryonic origin
  • 2.2. Classification of neurons
  • 2.3. Neuronal compartments and their functions
  • 2.4. Neuronal communication through a synapse
  • 2.5. Neuronal damage and repair strategies
  • 2.5.1. Alzheimer's disease (AD)
  • 2.5.2. Parkinson's disease (PD)
  • 2.5.3. Huntington's disease (HD).
  • 2.5.4. Traumatic spinal cord injury
  • 3. Astrocytes
  • 3.1. Astrocytes are a key cell type in the CNS
  • 3.2. Development, morphology, and distribution
  • 3.2.1. Embryology/lineage
  • 3.3. Are astrocytes neural stem cells?
  • 3.4. Astrocyte heterogeneity
  • 3.5. Astrocytes in aging and in disease
  • 3.5.1. Alzheimer's disease (AD)
  • 3.5.2. Parkinson's diseases (PD)
  • 3.5.3. Spinal cord injury (SCI) repair
  • 4. Microglia
  • 4.1. Introduction and embryogenesis
  • 4.2. Microglial heterogeneity
  • 4.3. Microglia and myelination
  • 4.4. Microglia and synapses
  • 4.5. Modification and engineering of microglia
  • 4.5.1. SCI
  • 4.5.2. Neurodegenerative diseases
  • 5. Oligodendrocytes
  • 5.1. Oligodendrocyte development and maturation
  • 5.1.1. Embryonic origin
  • 5.1.2. Oligodendrocyte migration during development
  • 5.1.3. Oligodendrocyte maturation
  • 5.2. Oligodendrocyte function
  • 5.3. Oligodendrocyte physiology
  • 5.4. Oligodendrocyte turn-over and pathology
  • 5.5. Oligodendrocytes in CNS disorders
  • 5.5.1. MS
  • 5.5.2. SCI
  • 5.5.3. Stroke
  • 6. Summary and conclusions
  • References
  • Chapter 4: Extracellular matrix of the nervous system
  • Chapter points
  • Abbreviations
  • 1. Introduction
  • 2. Composition and assembly of ECM in the nervous system
  • 2.1. Basement membranes
  • 2.1.1. Core components of basement membranes
  • 2.1.2. Basement membrane assembly
  • 2.1.3. Cell surface receptors for ECM components
  • 2.2. Interstitial neural ECM
  • 2.2.1. Perineuronal nets
  • 2.2.2. Matrix metalloproteinases
  • 3. ECM during brain development
  • 3.1. Neural progenitor proliferation and differentiation
  • 3.2. ECM in cell and axon migration
  • 3.2.1. Radial migration along RGCs
  • 3.2.2. Axonal migration
  • 3.3. Cortical folding
  • 3.4. Synapse formation
  • 4. Neural ECM in aging and disease
  • 4.1. Neurodegeneration
  • 4.2. Brain cancer.
  • 4.3. Cortical development and epilepsy
  • 4.3.1. Impact of ECM on cell fate and cortical malformation development
  • 5. Engineering ECM for human brain tissue models
  • 5.1. Decellularized ECM
  • 5.2. Hydrogels
  • 5.2.1. Collagen
  • 5.2.2. Hyaluronic acid
  • 5.2.3. Laminin
  • 5.2.4. Fibronectin
  • 5.2.5. Other gel formulations
  • 5.3. Bioactive hydrogels
  • 6. Summary
  • References
  • Chapter 5: The immune system and its role in the nervous system
  • 1. Introduction
  • 2. Overview of the immune system
  • 2.1. The innate and adaptive immune responses
  • 3. Immunology within the nervous system
  • 3.1. Immunology within the CNS
  • 3.1.1. Lymphatic structures and flow
  • 3.1.2. Resident immune cell populations and infiltrating populations
  • 3.2. Immunology within the peripheral nervous system (PNS)
  • 3.2.1. Resident immune cell populations
  • 4. Interactions between the nervous system and the systemic immune system
  • 4.1. Systemic neuroendocrine interactions
  • 4.2. Innervation of peripheral organ systems, organs, and tissue
  • 4.3. Direct interactions with immune cells
  • 4.4. Direct interactions with pathogens
  • 5. Neuroimmunity in injury, disease, and aging
  • 5.1. General characteristics of the neuroinflammatory response
  • 5.1.1. Fluid increase
  • 5.1.2. Cytokines
  • 5.1.3. Cell infiltration
  • 5.2. Neuroimmunity within specific diseases and disorders
  • 5.2.1. Trauma
  • 5.2.2. Cancer
  • 5.2.3. Psychiatric disorders
  • 5.2.4. Aging
  • 5.2.5. Autoimmunity
  • 6. Methods in neuroimmunology
  • 6.1. Model systems
  • 6.1.1. Animal models
  • 6.1.2. Derived living systems (ex vivo and in vitro models)
  • 6.1.3. Nonliving systems
  • 6.2. Experimental methods
  • 7. Neuroimmune engineering
  • 7.1.1. Microfluidic devices
  • 7.1.2. Organoids
  • 7.1.3. Scaffolds
  • 7.1.4. Cellular engineering
  • 8. Conclusion
  • References.
  • Chapter 6: Modulating disease states of the central nervous system: Outcomes of neuromodulation on microglia
  • 1. Introduction
  • 2. CNS seen from the microglial angle
  • 3. Memory disorders
  • 3.1. Relevant brain circuits for the study of MDs
  • 3.2. Deep brain stimulation
  • 3.3. Ultrasound stimulation
  • 3.4. Repetitive transcranial magnetic stimulation
  • 3.5. Outcomes of brain stimulation on glia
  • 4. Disorders of inhibition
  • 4.1. Relevant brain circuits for the study of disorders of inhibition
  • 4.2. Deep brain stimulation
  • 4.3. Ultrasound stimulation
  • 4.4. Intermittent theta burst and transcranial alternating current stimulation
  • 4.5. Outcomes of brain stimulation on glia
  • 5. Disorders of consciousness and coma
  • 5.1. Relevant brain circuits for the study of DOCs/coma
  • 5.2. Deep brain stimulation
  • 5.3. Ultrasound stimulation
  • 5.4. Repetitive transcranial magnetic and transcranial direct current stimulation
  • 5.5. Outcomes of brain stimulation on glia
  • 6. Challenges and limitations of the techniques
  • 7. Conclusion
  • References
  • Chapter 7: The effect of traumatic injuries on the nervous system
  • 1. Traumatic brain injury: Context and definitions
  • 2. Primary injury and the onset of traumatic brain injury pathophysiology
  • 2.1. Skull fractures
  • 2.2. Intracerebral hemorrhage
  • 2.3. Axonal injury
  • 3. The continuum of secondary injury
  • 4. Acute phase
  • 4.1. The blood-brain barrier
  • 4.2. Neurovascular damage starts in the blood-brain barrier
  • 4.3. Vascular consequences of BBB disruption
  • 4.4. Cellular energy crisis
  • 4.5. Glutamate discharge
  • 4.6. Cell death
  • 4.7. Acute neuroinflammation
  • 5. Subacute phase
  • 5.1. Subacute neuroinflammation
  • 5.2. Astrocyte reactivity
  • 5.3. Neurogenesis
  • 6. Chronic phase
  • 6.1. Age and chronic effects of TBI
  • 6.2. Neurodegeneration.
  • 6.3. Behavior and emotionality
  • 6.4. Cognitive impairments
  • 6.5. Diagnosis and intervention
  • 7. Repetitive TBI
  • 8. Future directions in neurotrauma research
  • 8.1. Modeling traumatic brain injury in the lab
  • 8.2. Identification of circulating biomarkers
  • References
  • Chapter 8: Chronic pain as a neurological disease and neural engineering strategies for its management
  • 1. Pain is a protective mechanism necessary for survival
  • 2. The nociceptive pain circuit
  • 2.1. Nociceptors are a subpopulation of sensory afferents
  • 2.2. Nociceptive signal transmission and integration in the spinal cord
  • 2.3. Nociceptive signal transmission and integration in the brain stem
  • 2.4. Pain processing in the brain
  • 2.4.1. The anterolateral pathway of DRG nociception
  • 2.4.2. The dorsal column/medial lemniscal (DCML) pathway of DRG nociception
  • 2.4.3. The trigeminal nociception
  • 2.4.4. The pain matrix in the brain
  • 2.5. Descending control of pain
  • 3. Chronic pain is a disease in its own right
  • 3.1. Peripheral sensitization
  • 3.2. Central sensitization
  • 4. Neuromodulation as an engineering approach in managing chronic pain
  • 4.1. Peripheral neuromodulation
  • 4.2. Central neuromodulation
  • 5. Conclusions
  • Acknowledgment
  • References
  • Section 2: Neural engineering strategies
  • Chapter 9: An overview of noninvasive imaging strategies in neural engineering
  • 1. Introduction
  • 2. Utility of imaging modalities to neural engineering
  • 3. Optical imaging
  • 3.1. Brightfield and fluorescence microscopy
  • 3.2. Confocal microscopy
  • 3.3. In vivo fluorescence microscopy
  • 3.4. Multiphoton microscopy (MPM)
  • 3.5. Super resolution microscopy (SRM)
  • 3.6. Raman spectroscopy
  • 3.7. Bioluminescence imaging (BLI)
  • 4. Ultrasound (US)
  • 5. Magnetic resonance imaging (MRI)
  • 6. X-rays and computed tomography (CT).